ArticleInternational journal of chronic obstructive pulmonary disease2020

Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy.

Chad Moretz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.